Abstract
Mosquito and tick-borne flaviviruses are the causative agents of some of the world's most important diseases, including dengue fever, yellow fever, Japanese encephalitis, tick-borne encephalitis and West Nile fever. Cumulatively, these viruses cause many millions of infections each year and impose a significant burden on public health resources, particularly in developing and newly developed countries. Vaccine development to eliminate flaviviral infections has been marked by uneven progress and a large number of setbacks. To date, no single approach has proved successful in leading to vaccine development against a wide range of flaviviruses, but the application of modern techniques to the problem is opening up new avenues of approach. This review summarizes some of the developments in vaccine research aimed at inducing protective immunity against flaviviral infections.
| Original language | English |
|---|---|
| Pages (from-to) | 409-415 |
| Number of pages | 7 |
| Journal | African Journal of Biotechnology |
| Volume | 9 |
| Issue number | 4 |
| Publication status | Published - 25 Jan 2010 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Attenuation
- Encephalitis
- Fever
- Flavivirus
- Hemorrhagic
- Vaccine
Fingerprint
Dive into the research topics of 'The development of flavivirus vaccines'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver